A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

NCT00791401 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Renal Impairment

Interventions

DRUG: ER OROS Paliperidone

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.